Low-dose aspirin versus placebo as adjunctive treatment in bipolar disorder (the Aspirin-Bipolar RCT): Results of exploratory biomarker analyses.
- DOI
- 10.1016/j.pnpbp.2026.111964
- Published
- 2026 Oct 2
- Container
- Progress in neuro-psychopharmacology & biological psychiatry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.pnpbp.2026.111964,
title = {Low-dose aspirin versus placebo as adjunctive treatment in bipolar disorder (the Aspirin-Bipolar RCT): Results of exploratory biomarker analyses.},
author = {Bruun CF and Long C and Krogh HB and Zarp J and Coello K and Frikke-Schmidt R and Ostrowski SR and Nielsen F and Giraldi A and Vinberg M and Faurholt-Jepsen M and Lange T and Kessing LV},
year = {2026},
journal = {Progress in neuro-psychopharmacology \& biological psychiatry},
doi = {10.1016/j.pnpbp.2026.111964},
url = {https://doi.org/10.1016/j.pnpbp.2026.111964}
}RIS
TY - JOUR TI - Low-dose aspirin versus placebo as adjunctive treatment in bipolar disorder (the Aspirin-Bipolar RCT): Results of exploratory biomarker analyses. AU - Bruun CF AU - Long C AU - Krogh HB AU - Zarp J AU - Coello K AU - Frikke-Schmidt R AU - Ostrowski SR AU - Nielsen F AU - Giraldi A AU - Vinberg M AU - Faurholt-Jepsen M AU - Lange T AU - Kessing LV PY - 2026 JO - Progress in neuro-psychopharmacology & biological psychiatry DO - 10.1016/j.pnpbp.2026.111964 UR - https://doi.org/10.1016/j.pnpbp.2026.111964 ER -
APA
CF, B., C, L., HB, K., J, Z., K, C., R, F., SR, O., F, N., A, G., M, V., M, F., T, L., & LV, K. (2026). Low-dose aspirin versus placebo as adjunctive treatment in bipolar disorder (the Aspirin-Bipolar RCT): Results of exploratory biomarker analyses.. Progress in neuro-psychopharmacology & biological psychiatry. https://doi.org/10.1016/j.pnpbp.2026.111964
Source records
- pubmed · retrieved 2026-11-10T13:25:16.352Z